Dr. Michael Marll is a physician-scientist specializing in pulmonary and critical care medicine. He is completing his fellowship training at Emory University, where his research focuses on the effects of HIV and tuberculosis on long-term lung health. His work centers on post-infectious pulmonary fibrosis and interstitial lung diseases (ILD), with a particular interest in the mechanisms and outcomes of progressive fibrotic lung injury.
We found differences in lung function at diagnosis and in trajectories of recovery during and after TB treatment by HIV and ART status. Future studies should explore whether this variability reflects differences in the pathophysiology of TB-associated lung damage with HIV coinfection.
Source: Conference 2024In individuals with newly diagnosed, moderate-to-severe pulmonary TB, a restrictive pattern of pulmonary function was the most common type of impairment. There was only moderate concordance between PFT patterns at TB diagnosis, treatment completion, and 6 months after treatment completion, suggesting significant heterogeneity in the natural history of TB-associated lung injury.
Source: Conference 2024